{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:12:45Z","timestamp":1763035965355},"reference-count":37,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2004,10,8]],"date-time":"2004-10-08T00:00:00Z","timestamp":1097193600000},"content-version":"vor","delay-in-days":3752,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Neurology"],"published-print":{"date-parts":[[1994,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Severe cholinergic loss occurs in the brains of patients with progressive supranuclear palsy. To evaluate the functional implications of this neuronal deficit, dose\u2010response curves were obtained in patients with progressive supranuclear palsy and normal control subjects undergoing intravenous cholinergic blockade (scopolamine) and stimulation (physo\u2010stigmine). Physostigmine had no significant neurobehavioral effects at any does in patients with progressive supranuclear palsy. Scopolamine, at low and medium doses, significantly impaired memory performance of both groups, but worsened the gait of only the patients. High\u2010dose scopolamine, which could not be tolerated by the patients, resulted in gait deterioration among control subjects. Thus, patients with progressive supranuclear palsy have increased sensitivity to cholinergic blockade compared to control subjects. Since loss of cholinergic neurons appears to contribute to the pathogenesis of certain cognitive and motor deficits found in progressive supranuclear palsy, the use of oral anticholinergics should ordinarily be avoided in this disorder. On the other hand, physostigmine at clinically tolerated dose levels seems to be terapeutically ineffective.<\/jats:p>","DOI":"10.1002\/ana.410360112","type":"journal-article","created":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T16:04:30Z","timestamp":1104595470000},"page":"55-61","source":"Crossref","is-referenced-by-count":32,"title":["Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy"],"prefix":"10.1002","volume":"36","author":[{"given":"I.","family":"Litvan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Blesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Nichelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"Atack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Mouradian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Grafman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. N.","family":"Chase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,10,8]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"15","volume-title":"Progressive supranuclear palsy: clinical and research appraches","author":"Duvoisin R","year":"1992"},{"key":"e_1_2_1_3_2","first-page":"3","volume-title":"Progressive supranuclear palsy: clinical and research approaches","author":"Steele JC","year":"1992"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00697397"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410180503"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410180504"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.16.5976"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.1.25"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.10.1593"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(91)90197-V"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410260318"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1990.00530120092016"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1990.00530050077015"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.54.9.832"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/089198879100400104"},{"key":"e_1_2_1_16_2","first-page":"194","article-title":"Comparative inhibitory effects of various physostigmine analogs against acetyl\u2010 and butyrylcholinesterases","volume":"249","author":"Atack JR","year":"1989","journal-title":"J Pharmacol Exp Ther."},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.24.11.1019"},{"key":"e_1_2_1_18_2","first-page":"329","volume-title":"Neuropsychological assessment","author":"Lezak MD","year":"1983"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2007.00818.x"},{"key":"e_1_2_1_20_2","first-page":"44","volume-title":"Progressive supranuclear palsy: clincial and research approaches","author":"Jellinger KA","year":"1992"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1987.01800170032006"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00231036"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1989.00520430059018"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1988.00520310028012"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1967.00470260014002"},{"key":"e_1_2_1_26_2","first-page":"291","article-title":"Acute effects of scopolamine in Hungtington's disease","volume":"37","author":"Nutt JG","year":"1983","journal-title":"Neurol."},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0013-4694(49)90221-7"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurpsyc.1952.02320230017002"},{"key":"e_1_2_1_29_2","first-page":"121","volume-title":"Principles and practice of sleep medicine","author":"Jones EJ","year":"1989"},{"key":"e_1_2_1_30_2","first-page":"421","article-title":"The thalamic changes of progressive supranuclear palsy","volume":"44","author":"Amano N","year":"1992","journal-title":"No To Shinkei."},{"key":"e_1_2_1_31_2","first-page":"347","article-title":"The central effects of scopolamine in man","volume":"3","author":"Safer D","year":"1971","journal-title":"Biol Psychiatry."},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00542208"},{"key":"e_1_2_1_33_2","first-page":"89","volume-title":"Progressive supranuclear palsy: clinical and research approaches","author":"Ruberg M","year":"1992"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.50.9.1197"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/115.4.1181"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410180502"},{"key":"e_1_2_1_37_2","first-page":"254","volume-title":"Progressive supranuclear palsy: clinical and research approaches","author":"Litvan I","year":"1992"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(87)90143-2"}],"container-title":["Annals of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fana.410360112","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.410360112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T12:32:37Z","timestamp":1698150757000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.410360112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,7]]}},"alternative-id":["10.1002\/ana.410360112"],"URL":"https:\/\/doi.org\/10.1002\/ana.410360112","archive":["Portico"],"relation":{},"ISSN":["0364-5134","1531-8249"],"issn-type":[{"value":"0364-5134","type":"print"},{"value":"1531-8249","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,7]]}}}